Vericel Corporation (VCEL)
NASDAQ·Healthcare·Biotechnology
$35.86
-2.87%
Mkt Cap $1.71B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $90.97M | $92.92M | +2.14% | $0.45 | $0.45 | +0.00% | — | — |
| Q4 2025 Nov 6, 2025 | $92.66M | $67.50M | -27.15% | -$0.02 | $0.10 | +600.00% | — | — |
| Q3 2025 Jul 31, 2025 | $64.57M | $63.24M | -2.06% | -$0.04 | -$0.01 | +75.00% | — | — |
| Q2 2025 May 8, 2025 | $64.81M | $52.60M | -18.84% | -$0.09 | -$0.23 | -155.56% | — | — |
| Q1 2025 Feb 27, 2025 | $58.12M | $75.38M | +29.69% | $0.31 | $0.38 | +22.58% | — | — |
| Q4 2024 Nov 7, 2024 | $77.97M | $57.91M | -25.73% | -$0.05 | -$0.02 | +60.00% | — | — |
| Q3 2024 Aug 1, 2024 | $55.18M | $52.66M | -4.56% | -$0.10 | -$0.10 | +0.00% | — | — |
| Q2 2024 May 8, 2024 | $49.07M | $51.28M | +4.51% | -$0.11 | -$0.08 | +27.27% | — | — |
| Q1 2024 Feb 29, 2024 | $63.93M | $65.00M | +1.67% | $0.17 | $0.26 | +52.94% | — | — |
| Q4 2023 Nov 8, 2023 | $45.15M | $45.58M | +0.95% | -$0.13 | -$0.08 | +38.46% | — | — |
| Q3 2023 Aug 2, 2023 | $44.98M | $45.92M | +2.09% | -$0.13 | -$0.11 | +15.38% | — | — |
| Q2 2023 May 10, 2023 | $37.87M | $41.02M | +8.31% | -$0.13 | -$0.16 | -23.08% | — | — |
| Q1 2023 Feb 23, 2023 | $52.88M | $52.69M | -0.35% | $0.04 | $0.12 | +238.98% | — | — |
| Q4 2022 Nov 9, 2022 | $39.91M | $38.55M | -3.39% | -$0.12 | -$0.14 | -16.67% | — | — |
| Q3 2022 Aug 3, 2022 | $38.35M | $37.05M | -3.39% | -$0.13 | -$0.19 | -46.15% | — | — |
| Q2 2022 May 4, 2022 | $34.30M | $36.07M | +5.16% | -$0.15 | -$0.15 | +0.00% | — | — |
| Q1 2022 Feb 24, 2022 | $48.99M | $47.59M | -2.86% | $0.14 | $0.09 | -35.71% | — | — |
| Q4 2021 Nov 9, 2021 | $38.60M | $34.51M | -10.61% | -$0.03 | -$0.11 | -305.31% | — | — |
| Q3 2021 Aug 4, 2021 | $36.67M | $39.52M | +7.77% | -$0.06 | -$0.08 | -33.33% | — | — |
| Q2 2021 May 5, 2021 | $32.08M | $34.57M | +7.74% | -$0.06 | -$0.07 | -16.67% | — | — |